Chromosomal and plasmid-mediated fluoroquinolone resistance in human Salmonella enterica infection in Ghana

Simple item page
dc.contributor.authorAcheampong Godfred
dc.contributor.authorOwusu-Ofori Alex
dc.contributor.authorOwusu-Dabo Ellis
dc.contributor.authorOwusu Michael
dc.contributor.authorOsei Isaac....et al
dc.date.accessioned2023-12-11T12:34:44Z
dc.date.available2023-12-11T12:34:44Z
dc.date.issued2019
dc.descriptionThis article is published by BioMed Central and is also available at https://doi.org/10.1186/s12879-019-4522-1
dc.description.abstractBackground: Salmonella infection poses significant public health threat globally, especially in resource-limited countries. Emergence and spread of antibiotic resistant strains to fluoroquinolones have led to treatment failures and increased mortality in Salmonella infection. However, there is dearth of information regarding mechanisms of resistance to fluoroquinolones in Ghana. This study therefore sought to identify chromosomal mutations and plasmid-mediated resistance as possible mechanisms of fluoroquinolone resistance from clinical isolates in Ghana. Methods: This was a retrospective study of archived isolates biobanked at Kumasi Centre for Collaborative Research in Tropical Medicine, Ghana. Isolates were obtained from blood, stool and oropharynx samples at two hospitals, between May, 2016 and January, 2018. Salmonella identification was done using standard microbiological protocols and antibiotic susceptibility testing performed by Kirby-Bauer disc diffusion method. Isolates with intermediate susceptibility and/or resistance to nalidixic acid and/or ciprofloxacin were selected and examined for chromosomal mutations by Sanger sequencing and plasmid-mediated resistance by PCR. Results: Of 133 biobanked isolates cultured, 68 (51.1%) and 16 (12%) were identified as Salmonella Typhi and non typhoidal Salmonella (NTS), respectively. Sequence analysis of gyrA gene revealed the presence of 5 different nonsynonymous mutations, with the most frequent mutation (Ile203Ser) occurring in 12 out of 13 isolates tested. Gyrase B (gyrB) gene had 1 nonsynonymous mutation in 3 out of 13 isolates, substituting phenylalanine with leucine at codon 601 (Phe601Leu). No mutation was observed in parC and parE genes. Two NTS isolates were found to harbour qnrS plasmid-mediated resistant gene of molecular size 550 bp with high ciprofloxacin MIC of 0.5 μg/ml. Conclusion: This study reports for the first time in Ghana plasmid-mediated fluoroquinolone resistant gene qnrS in Salmonella clinical isolates. Nonsynonymous mutations of gyrA and gyrB genes likely to confer Salmonella reduced susceptibility to ciprofloxacin were also reported.
dc.description.sponsorshipKNUST
dc.identifier.citationAcheampong et al. BMC Infectious Diseases (2019) 19:898 https://doi.org/10.1186/s12879-019-4522-1
dc.identifier.uri10.1186/s12879-019-4522-1
dc.identifier.urihttps://ir.knust.edu.gh/handle/123456789/14766
dc.language.isoen
dc.publisherBioMed Central
dc.titleChromosomal and plasmid-mediated fluoroquinolone resistance in human Salmonella enterica infection in Ghana
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Chromosomal and plasmid-mediated fluoroquinolone resistance in human salmonella enterica infection in Ghana.pdf
Size:
788.87 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description:
Download
Collections
Articles